Difference between revisions of "Projects"
OKripfgans (talk | contribs) |
|||
| Line 11: | Line 11: | ||
Work is focused on establishing a QIBA framework to organize and pursue the research-oriented groundwork and the standards-oriented profile development/implementation necessary to put such biomarkers into practice in the hands of clinical and pharma users. | Work is focused on establishing a QIBA framework to organize and pursue the research-oriented groundwork and the standards-oriented profile development/implementation necessary to put such biomarkers into practice in the hands of clinical and pharma users. | ||
| + | |||
| + | |||
| + | ==[[Ultrasound]]== | ||
| + | |||
| + | [[Ultrasound SWS Biomarker Ctte|Ultrasound SWS Biomarker Committee]] | ||
| + | |||
| + | [[AIUM/QIBA Ultrasound Volume Blood Flow Biomarker Ctte|Ultrasound Volume Blood Flow Biomarker Committee] | ||
| + | |||
| + | Quantitative Volume Blood Flow is the focused of this committee. A group of clinical and basic science researchers are pursuing this effort in conjunction with industry partners. | ||
Revision as of 04:16, 18 November 2015
DCE-MRI
<one or two line summary of the project/goal>
FDG-PET
<one or two line summary of the project/goal>
Volumetric CT
Volumetric CT-based biomarkers for parenchymal mass (lung nodule) response assessment has been selected to provide a concrete target to start on.
Work is focused on establishing a QIBA framework to organize and pursue the research-oriented groundwork and the standards-oriented profile development/implementation necessary to put such biomarkers into practice in the hands of clinical and pharma users.
Ultrasound
Ultrasound SWS Biomarker Committee
[[AIUM/QIBA Ultrasound Volume Blood Flow Biomarker Ctte|Ultrasound Volume Blood Flow Biomarker Committee]
Quantitative Volume Blood Flow is the focused of this committee. A group of clinical and basic science researchers are pursuing this effort in conjunction with industry partners.